Article MM8871, Screening for Hepatitis C Virus (HCV) in Adults Article MM10184, ICD-10 Coding Revisions to National Coverage Determinations (NCDs) UnitedHealthcare Commercial Policy Hepatitis Screening
· When coding HCV screening, use HCPCS Level II code G0472, Hepatitis C antibody screening, for individual at high risk and other covered indication. For high-risk groups, the HCPCS Level II code must be accompanied by ICD-10 code Z72.89 Other problems related to lifestyle.
Hepatitis C ICD-10 Codes HCV codes ICD-10 Carrier of unspecified viral hepatitis Z22.50 Carrier of viral hepatitis C Z22.52 Carrier of other viral hepatitis Z22.59 Personal history of other infectious and parasitic diseases Z86.19 Chronic viral hepatitis C B18.2 Unspecified viral hepatitis C without hepatic coma B19.20 Unspecified viral hepatitis C with hepatic coma B19.21
Medicare covers a Hepatitis C screening test if your primary care doctor or other qualified health care provider orders one and you meet one or more of these conditions: You’re at high risk because you use or have used illicit injection drugs. You ’re at high risk because you h ad a blood transfusion before 1992. You were born between 1945 ...
· Z11.59 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z11.59 became effective on October 1, 2021. This is the American ICD-10-CM version of Z11.59 - other international versions of ICD-10 Z11.59 may differ.
Hepatitis C screening tests Medicare covers a Hepatitis C screening test if your primary care doctor or other qualified health care provider orders one and you meet one or more of these conditions: You're at high risk because you use or have used illicit injection drugs.
ICD-10-CM Diagnosis Code B18 B18.
Generally, Medicare Part D (prescription drug coverage) covers Hepatitis A shots when medically necessary. Medicare Part B (Medical Insurance) covers Hepatitis B shots, which usually are given as a series of 3 shots over a 6-month period (you need all 3 shots for complete protection).
Hepatitis C antibody screening, for individual at high risk and other covered indication(s) G0472 - HCPCS Codes - Codify by AAPC.
Test Name:HEPATITIS PANEL, ACUTE (AMA)CPT Code(s):80074Test Includes:Hepatitis A, IgM Hepatitis B Core Antibody, IgM Hepatitis B Surface Antigen Hepatitis C Antibody with ConfirmationPreferred Specimen:8.0 mL serumContainer:4 - SST (gold)14 more rows
52 will replace Z11. 59 (Encounter for screening for other viral diseases), which the CDC previously said should be used when patients being screened for COVID-19 have no symptoms, no known exposure to the virus, and test results that are either unknown or negative.
Policy: Effective for claims with dates of service on or after January 1, 2013, vaccine codes 90653, 90672, 90685, 90686, 90687, 90688, 90739, and Q2033 will be payable by Medicare.
Providing free preventive care. Under the ACA, all new health plans must cover certain preventive services—like shots and screening tests—without charging a deductible or co-pay. This includes important viral hepatitis services such as hepatitis A and B vaccination and hepatitis B and C testing.
Hepatitis C screening at least once in a lifetime for all adults aged 18 years and older, except in settings where the prevalence of HCV infection (HCV RNA‑positivity) is less than 0.1%*
8871 - 04.4 Effective for claims with dates of service on or after June 2, 2014, Medicare contractors shall allow one HCV screening, HCPCS G0472, per lifetime, for adult beneficiaries who were born from 1945 through 1965 who are not considered high risk.
(2) the service must be medically necessary or indicated. Once these two criteria are met, Medicare pays for most clinical laboratory tests based on the Laboratory Fee Schedule.
80061 Lipid panel A lipid panel includes the following tests: total serum cholesterol (82465), high–density cholesterol (HDL cholesterol) by direct measurement (83718), and triglycerides (84478). Blood specimen is obtained by venipuncture.
Medicare covers a screening test if your primary care doctor or other qualified health care provider orders one and you meet one or more of these conditions: You’re at high risk because you use or have used illicit injection drugs .
assignment. An agreement by your doctor, provider, or supplier to be paid directly by Medicare, to accept the payment amount Medicare approves for the service, and not to bill you for any more than the Medicare deductible and coinsurance.
Please Note: This may not be an exhaustive list of all applicable Medicare benefit categories for this item or service.
09/2014 - Effective for services performed on or after June 2, 2014, the Centers for Medicare & Medicaid Services will cover screening for hepatitis C virus consistent with the grade B recommendations by the USPSTF for the prevention or early detection of an illness or disability and is appropriate for individuals entitled to benefits under Medicare Part A or enrolled under Part B.
This NCD has been or is currently being reviewed under the National Coverage Determination process. The following are existing associations with NCAs, from the National Coverage Analyses database.
Preventive Services Task Force (USPSTF), is reasonable and necessary for the prevention or early detection of an illness or disability and is appropriate for individuals entitled to benefits under Part A or enrolled under Part B, as described below.
The Medicare Advantage Policy Guideline documents are generally used to support UnitedHealthcare Medicare Advantage claims processing activities and facilitate providers’ submission of accurate claims for the specified services. The document can be used as a guide to help determine applicable:
Hepatitis refer to inflammation of the liver that can caused by virus infections that affect the liver. Viral hepatitis is a relatively common disease (25 patients in every 100,000 citizens in the US) caused by a diverse group of hepatotropic agents that lead to liver inflammation and liver cell death.
The CDC has recommendations regarding Hepatitis screening for both hepatitis B and hepatitis C for persons at high risk for infection.